JPMorgan (AMJB) offers uncapped S&P 500 futures barrier notes
JPMorgan Chase Financial Company LLC, fully guaranteed by JPMorgan Chase & Co., is offering Uncapped Accelerated Barrier Notes linked to the S&P 500® Futures Excess Return Index. Each note has a $1,000 minimum denomination and is expected to price around February 6, 2026 and mature on February 11, 2030.
At maturity, if the index is above its initial level, investors receive $1,000 plus at least 2.00 times the index gain. If the index is flat or down but still at or above 79.50% of the initial value, investors receive only their $1,000 principal. If the index closes below this barrier, repayment is reduced one-for-one with the index loss, so investors can lose more than 20.50% and up to all of their principal.
The notes pay no interest, are unsecured and unsubordinated, and expose holders to the credit risk of both JPMorgan Financial and JPMorgan Chase & Co. The issuer estimates the current value at about $977.80 per $1,000 note, and expects the final estimated value at pricing to be no lower than $900. The notes will not be listed on an exchange, and secondary market liquidity is not assured. The underlying index is based on E-mini S&P 500 futures and is subject to futures market risks, including volatility, negative roll yield and trading limits.
Positive
- None.
Negative
- None.
FAQ
What are the JPMorgan AMJB Uncapped Accelerated Barrier Notes?
The notes are unsecured structured investments issued by JPMorgan Chase Financial Company LLC, guaranteed by JPMorgan Chase & Co., that pay no interest and offer leveraged exposure to the S&P 500® Futures Excess Return Index with potential loss of principal at maturity.
How do the AMJB notes linked to the S&P 500 Futures Excess Return Index pay off at maturity?
If the index finish value is above its initial level, each $1,000 note pays $1,000 plus the Index Return multiplied by an Upside Leverage Factor of at least 2.00. If the index is at or above 79.50% of the initial value, investors receive their $1,000 principal. Below that barrier, repayment is reduced in line with the index loss, potentially down to zero.
What are the main risks of investing in the JPMorgan AMJB structured notes?
Key risks include the possibility of losing more than 20.50% and up to all principal if the index ends below the 79.50% barrier, no interest payments, credit risk of JPMorgan Financial and JPMorgan Chase & Co., lack of exchange listing and potentially limited secondary market liquidity, as well as futures-related risks such as volatility, negative roll returns and trading disruptions.
How is the estimated value of the AMJB notes determined?
The issuer estimates the note value as the sum of a fixed-income component, valued using an internal funding rate, and embedded derivatives priced by internal models. If priced on the reference date, the estimated value would be about $977.80 per $1,000 note, and the final estimated value at pricing will not be less than $900.00 per $1,000 note. The original issue price includes structuring fees, hedging costs and expected hedging profits.
What is the underlying S&P 500 Futures Excess Return Index for the AMJB notes?
The underlying is the S&P 500® Futures Excess Return Index (Bloomberg: SPXFP), which tracks the performance of the nearest-maturity E-mini S&P 500 futures contracts on the Chicago Mercantile Exchange, including the effect of quarterly contract rolls. It is an excess return index and does not reflect interest on collateral.
Do the JPMorgan AMJB barrier notes pay interest or provide any interim income?
No. The notes do not pay periodic interest or dividends. All potential return is realized only at maturity, based on the final level of the S&P 500 Futures Excess Return Index relative to its initial level and the 79.50% barrier.
Are the AMJB notes treated as debt for U.S. federal income tax purposes?
The issuer currently expects to treat the notes as open transactions that are not debt instruments for U.S. federal income tax purposes, with gains or losses generally treated as capital if held more than one year, but this treatment is not certain and could change with future IRS guidance. Investors are urged to consult their tax advisers.